Allergan USA, Inc.

Lawsuit Filings

Class Action Alleges AbbVie, Allergan, Forest Labs Blocked Generic Form of Bystolic Beta Blocker from Market

September 16, 2020 A class action alleges AbbVie, Allergan and Forest Labs conspired to suppress market competition for Bystolic, a blockbuster high blood pressure treatment drug.

Allergan Facing Another Class Action Over Recalled Biocell Breast Implants

December 5, 2019 Another proposed class action claims the maker of now-recalled Biocell textured breast implants failed to warn patients that the product could increase their risk of developing cancer.

Allergan Hit with More Proposed Class Action Litigation Over Biocell Implant Cancer Risk

October 9, 2019 Allergan faces more potential class action litigation over its recalled Biocell textured breast implants' connection to BIA-ALCL, a cancer of the immune system.